In addition, the high expression of both cytoplasmic S1P1 and ERK-1/2 or phosphorylated AKT in the same tumor is associated with shorter disease-specific survival time (Ohotski et al., 2012a). This evidence concerns the gene S1PR1 and neoplasm.